Novavax | NVAX - Stammkapital

Aktienkurs
8.12
Täglich Wechseln
-0.42 -4.92%
Monatlich
-24.81%
Jährlich
38.57%
Q2 Prognose
7.90




Stammkapital Veränderung Datum
Adma Biologics USD 237.88M 457K 2025-12
Agenus USD 35.32M 2.51M 2025-12
AstraZeneca USD 1.55B 206K 2025-12
BioCryst Pharmaceuticals USD 213.06M 2.54M 2025-12
Cassava Sciences USD 48.31M 0 2025-12
Geron USD 638.36M 338K 2025-12
GlaxoSmithKline GBP 4.08B 49.43M 2025-12
MannKind USD 307.83M 806K 2025-12
Merck USD 2.49B 15.79M 2025-09
Minerva Neurosciences USD 1000 0 2024-09
Moderna USD 391M 2M 2025-09
Novartis USD 1.91B 10.64M 2025-12
Novavax USD 162.58M 106K 2025-12
Pfizer USD 5.69B 1000K 2025-09
Sarepta Therapeutics USD 104.96M 196K 2025-12
TG Therapeutics USD 155.21M 2.81M 2025-09